Anthem Biosciences IPO: GMP, Date, Price, Size & Is It Good to Invest?
01 July 2025 · Sachin Gadekar
Anthem Biosciences IPO: GMP, Date, Price, Size & Is It Good to Invest?
Anthem Biosciences IPO Subscription Status
Updated Subscription Status:
The Anthem Biosciences IPO continues to attract strong investor interest. By the end of Day 2, July 15, 2025, the IPO was subscribed 3.48 times overall. The retail portion saw healthy demand with 2.21 times subscription, while the Non-Institutional Investor (NII) category led the surge at 10.26 times. However, the Qualified Institutional Buyers (QIB) segment remains at 0.62 times so far. With the Grey Market Premium (GMP) hovering around ₹123, market sentiment indicates a robust listing gain potential for investors eyeing this ₹3,395-crore IPO.
Latest Update (July 14, 2025): Anthem Biosciences’ ₹3,395 crore IPO has officially opened for subscription today and continues to attract strong grey market interest. The latest GMP (Grey Market Premium) for Anthem Biosciences IPO is trending around ₹95–₹105 per share, indicating robust demand among investors. This suggests a premium listing of about 17%–18% over the upper price band of ₹570. Investors should keep an eye on the live GMP, Kostak, and Subject to Sauda rates over the next two days before placing their bids.
Introduction
Bengaluru-based Anthem Biosciences Limited, a leading contract research and manufacturing services (CRAMS) company, is gearing up for its much-anticipated IPO in the Indian primary market. The IPO is likely to attract significant interest from retail investors and institutions alike, thanks to the company’s strong growth story in biotech research and contract manufacturing.
In this guide, Ultra covers every key aspect — Anthem Biosciences IPO GMP, date, share price, size, DRHP insights, and whether this IPO might be good or bad for your investment portfolio.
Anthem Biosciences Limited
Incorporated: 2007
Headquarters: Bengaluru, India
Anthem Biosciences is a contract research, development, and manufacturing organization (CRDMO) that works with global pharmaceutical and biotech companies. It offers a wide range of services — from drug discovery and research to large-scale manufacturing of active pharmaceutical ingredients (APIs) and specialty chemicals.
The company has made a mark in biotech R&D, custom synthesis, chemical intermediates, and contract development manufacturing for big pharmaceutical brands globally.
Anthem Biosciences IPO: Key Details
| Particulars | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Assets | ₹879.62 Cr | ₹592.91 Cr | ₹304.99 Cr |
| Revenue | ₹884.78 Cr | ₹763.44 Cr | ₹517.85 Cr |
| Profit After Tax | ₹152.93 Cr | ₹118.90 Cr | ₹112.14 Cr |
| EBITDA | ₹212.82 Cr | ₹72.64 Cr | ₹107.29 Cr |
| Net Worth | ₹505.71 Cr | ₹341.81 Cr | ₹221.37 Cr |
| Total Borrowing | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr |
Anthem Biosciences IPO GMP Today
The Anthem Biosciences IPO GMP (Grey Market Premium) is one of the most tracked indicators for IPO investors. While the GMP can give an idea of possible listing gains, the official GMP for Anthem Biosciences IPO is not yet available as the IPO dates and price band are still to be finalized.
Stay connected with Ultra for live updates on Anthem Biosciences IPO GMP today when unofficial trading begins closer to the opening date.
Anthem Biosciences IPO Date & Timeline
| Event | Date |
|---|---|
| IPO Open Date | To be announced |
| IPO Close Date | To be announced |
| Allotment Date | To be announced |
| Listing Date | To be announced |
| Cut-off for UPI Mandate | 5 PM on the closing day |
Anthem Biosciences IPO Price
The official Anthem Biosciences IPO share price band is not declared yet. However, market experts expect a competitive price based on the company’s robust financials and comparable biotech IPOs.
The final IPO price will be decided through the bookbuilding process managed by JM Financial Limited.
Anthem Biosciences IPO Size
As per the Draft Red Herring Prospectus (DRHP), Anthem Biosciences is planning an IPO worth around ₹3,395 crore, entirely via an Offer For Sale (OFS). This means existing shareholders are offloading a portion of their stake; the company is not issuing fresh equity.
Anthem Biosciences Financial Performance
| Particulars | 30 Sep 2024 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Assets | ₹2,692.51 Cr | ₹2,398.11 Cr | ₹2,014.46 Cr | ₹1,618.87 Cr |
| Revenue | ₹910.85 Cr | ₹1,483.07 Cr | ₹1,133.99 Cr | ₹1,280.24 Cr |
| Profit After Tax | ₹244.31 Cr | ₹367.31 Cr | ₹385.19 Cr | ₹405.54 Cr |
| EBITDA | ₹327.50 Cr | ₹519.96 Cr | ₹446.05 Cr | ₹587.31 Cr |
| Net Worth | ₹2,204.37 Cr | ₹1,924.66 Cr | ₹1,740.67 Cr | ₹1,355.00 Cr |
| Total Borrowing | ₹131.26 Cr | ₹232.53 Cr | ₹125.06 Cr | ₹35.49 Cr |
Is Anthem Biosciences IPO Good or Bad?
Investors looking at Anthem Biosciences IPO review should consider these points:
Positives:
Strong presence in contract research and manufacturing — a sunrise industry.
Established promoter group with a solid track record.
Global clientele in pharma and biotech.
Consistent profits and healthy EBITDA margins.
High entry barriers in biotech R&D and custom manufacturing.
Risks:
Entirely an OFS — no fresh capital for expansion.
Regulatory risks due to the nature of the pharma sector.
Dependence on a few large clients could pose concentration risk.
In summary, Anthem Biosciences IPO looks promising for investors with a medium to long-term horizon, but as always, review the DRHP, valuation, and your risk appetite.
How to Buy Anthem Biosciences IPO Shares
Buying Anthem Biosciences IPO is simple:
Open a Demat Account — Register with a SEBI-approved broker or trusted digital investment platform like Ultra’s partners.
Complete KYC — Ensure PAN, Aadhaar, and bank details are verified.
Check IPO Details — When the IPO opens, log in to your trading app and find Anthem Biosciences IPO under ‘Current IPOs’.
Place Your Bid — Choose your lot size. Bid at the cutoff price to increase allotment chances.
Approve Mandate — Complete UPI mandate before the cut-off time.
Check Allotment — Watch for the allotment date and status updates.
Listing Day — If allotted, your shares will be credited to your Demat account for trading.
FAQs: Anthem Biosciences IPO
Q1: What is the Anthem Biosciences IPO GMP today? Currently, there is no official GMP. It will be updated closer to the IPO opening.
Q2: What is Anthem Biosciences IPO date? The IPO date is not yet announced. Stay tuned to Ultra for the official schedule.
Q3: What is Anthem Biosciences IPO price band? The price band is yet to be declared. The company will announce it closer to the open date.
Q4: What is Anthem Biosciences IPO size? The estimated IPO size is around ₹3,395 crore, fully an Offer For Sale.
Q5: Is Anthem Biosciences IPO good or bad? The IPO has positives like consistent profits, strong market positioning, and growth potential. However, do your own research or consult an advisor.